Skåne University Hospital / Lund University Cancer Centre
Southern Sweden's university hospital and Lund University's cancer centre, known for the population-wide SCAN-B breast cancer sequencing project.
Skåne University Hospital in Lund and Malmö is the tertiary cancer centre for southern Sweden, and Lund University Cancer Centre coordinates research across its Medicon Village campus. Åke Borg and Lao Saal established the Sweden Cancerome Analysis Network–Breast (SCAN-B), which has sequenced the transcriptomes of breast cancers from consecutive patients across the region since 2010 and reports gene expression subtypes back into care, and Lund groups are strong in melanoma and prostate genomics, paediatric oncology and radiation physics linked to the MAX IV synchrotron. Lund also spun out antibody company BioInvent and hosts a Swedish node for CAR-T and haematological trials.
- SCAN-B breast cancer sequencing
- Cancer genomics
- Paediatric oncology
- Radiation physics
- Medicon Village
Pages like this
not linked directly; found by shared links- InstitutionHUS Comprehensive Cancer Center, Helsinki University Hospital
Shares Karolinska University Hospital, Whole-exome & whole-genome sequencing, Germline (hereditary) testing, HR-positive / HER2-negative breast cancer.
- InstitutionSOLTI Cancer Research Group
Shares PAM50 / intrinsic subtypes, RNA sequencing & expression profiling, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
- InstitutionCancer Research UK Cambridge Centre / CRUK Cambridge Institute
Shares PAM50 / intrinsic subtypes, RNA sequencing & expression profiling, Whole-exome & whole-genome sequencing, HR-positive / HER2-negative breast cancer.
- InstitutionKorle Bu Teaching Hospital
Shares Germline (hereditary) testing, Triple-negative breast cancer (TNBC), Prostate cancer, HR-positive / HER2-negative breast cancer.
- InstitutionShizuoka Cancer Center
Shares RNA sequencing & expression profiling, Whole-exome & whole-genome sequencing, Germline (hereditary) testing.
- InstitutionLagos University Teaching Hospital
Shares Germline (hereditary) testing, Triple-negative breast cancer (TNBC), Prostate cancer, HR-positive / HER2-negative breast cancer.
- InstitutionUNC Lineberger Comprehensive Cancer Center
Shares PAM50 / intrinsic subtypes, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
- InstitutionHospital Clínic de Barcelona / IDIBAPS
Shares PAM50 / intrinsic subtypes, RNA sequencing & expression profiling, Whole-exome & whole-genome sequencing, HR-positive / HER2-negative breast cancer.